Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007674. doi: 10.1101/cshperspect.a007674.

    Generating β cells from stem cells-the story so far.

    Source

    Diabetes Center, Department of Medicine, University of California, San Francisco, San Francisco, California, USA. mhebrok@diabetes.ucsf.edu

    Abstract

    Despite intensive research, a treatment for diabetic patients that completely restores normoglycemia for an indefinite period of time remains elusive. Although islet transplantation temporarily confers normoglycemia to patients, the lack of a renewable source of insulin-producing β cells hampers the use of this treatment option. Although significant hurdles remain, recent advances in stem cell biology indicate that generation of fully matured β cells from uncommitted progenitor cells, including human embryonic stem cells and induced pluripotent stem cells derived from somatic cell populations, is becoming an achievable goal.

    PMID:
    22675664
    [PubMed - in process]
    PMCID:
    PMC3367541
    Free PMC Article

    Images from this publication.See all images (2)Free text

    Figure 2.
    Figure 1.

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk